Related Experiment Video
Updated: Jul 15, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
[When depression does not end. Resistant depression: recent clinical and therapeutic aspects]
D Gayetot1, M Ansseau, J M Triffaux
1Hôpital de Jour Universitaire La Clé, ULg, Liège, Belgique.
Revue Medicale De Liege
|April 28, 2007
Summary
Depression is a significant global health concern, with many patients not responding to standard treatments. New strategies like medication adjustments, psychotherapy, and brain stimulation offer hope for treating resistant depression.
Area of Science:
- Psychiatry and Public Health
- Neuroscience and Pharmacology
Context:
- Depression is a leading cause of global disability.
- An estimated 30-45% of major depressive disorder patients exhibit treatment resistance.
- Residual symptoms are prevalent, impacting quality of life.
Purpose:
- To review the latest clinical and therapeutic advancements for resistant depression.
- To highlight emerging treatment modalities beyond conventional approaches.
Summary:
- Resistant depression poses a significant challenge, with a substantial portion of patients showing inadequate response to antidepressants.
- Current management includes augmentation with lithium or thyroid hormones.
- Novel strategies encompass pharmacological approaches (switching/augmentation), psychotherapy, and cerebral stimulation technologies.
Impact:
- Improved understanding of treatment-resistant depression.
- Guidance on integrating new therapeutic options.
- Potential for enhanced patient outcomes in managing complex depressive disorders.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:29Psychodynamic Therapy
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...